GB:CLBX Stock Latest News
Company AnnouncementsCelLBxHealth inks Swiss biotech deal in fast-growing radiopharmaceuticals1w ago
Company AnnouncementsCelLBxHealth cuts losses, secures pharma deals and targets revenue surge in 20271w ago
Company AnnouncementsCelLBxHealth Secures New U.S. Pharma Contract for Parsortix CTC Analysis2w ago- Company AnnouncementsCelLBxHealth Highlights Parsortix Breakthrough in Glioblastoma Liquid Biopsy2M ago
Company AnnouncementsCelLBxHealth’s Parsortix platform bolsters ADC monitoring credentials in peer‑reviewed CTC study3M ago
Company AnnouncementsCelLBxHealth Ties Staff Rewards to Share Price With Large Option Grant3M ago
Company AnnouncementsCelLBxHealth Targets 50% Revenue Growth as CEO Search Begins3M ago
Company AnnouncementsCelLBxHealth CEO departs as board backs CTC growth strategy3M ago
Company AnnouncementsCelLBxHealth slashes costs and pivots to partnerships after revenue slide4M ago- Company AnnouncementsCelLBxHealth sets date for 2025 results and investor webcast4M ago
Company AnnouncementsCelLBxHealth strikes AstraZeneca services deal for CTC-powered analytics5M agoCompany AnnouncementsCelLBxHealth teams with AdventHealth to trial CTC-based cancer monitoring in community care5M ago
- Company AnnouncementsCelLBxHealth partners with Royal Marsden on CTC-DNA study in advanced lung cancer6M ago
Company AnnouncementsCelLBxHealth strengthens board with new CEO and non-executive directors6M ago- Company AnnouncementsCelLBxHealth Drops FDA Device Listing to Refocus Spending on Growth8M ago
Company AnnouncementsCelLBxHealth Tightens Costs and Reshapes Strategy as 2025 Revenues Miss Target9M ago
Company AnnouncementsCelLBxHealth refreshes board and appoints new CEO to drive CTC growth strategy9M agoCompany AnnouncementsCelLBxHealth Executives and ESOT Boost Holdings After Oversubscribed Placing10M ago